A novel organisation tin perform a onetime minimally invasive catheter-based per cutaneous physical care for that has shown to significantly cut blood pressure--in equally fiddling equally thirty seconds.
This novel technology, developed past times Vessix Vascular, has the potential to assistance the i inwards 3 adults inwards the the US who endure from hypertension-- a status that is to a greater extent than mutual than cancer, diabetes too coronary artery affliction combined.
Today, anti-hypertensive drugs are the brain handling for hypertension. But despite the widespread purpose of drugs, solely nigh one-half of hypertensive patients around the the world are good controlled, fifty-fifty when multiple medications are taken at optimal dosages.
The V2 organisation performs a novel procedural handling called renal denervation, which physician Mehemet Oz has called "a profound game changer." It uses a brusk boom of radiofrequency (RF) liberate energy to disable the nerves surrounding the arteries leading to the kidneys, treating i of the fundamental physiological contributors to hypertension.
The V2 Catheter is a balloon catheter alongside a unique configuration of RF electrodes mounted on its exterior, which makes the physical care for faster too safer. It delivers precise temperature controlled RF liberate energy from the V2 RF Generator to both renal arteries inwards lx seconds, piece the solely other competitively marketed Renal Denervation organisation takes 50-60 minutes.
The rapidity of the V2 handling promises to cut patient discomfort too equally exposure to radiations for both the patient too the interventional cardiologist performing the procedure.